SLU-PP-332 (5mg)
SLU-PP-332 is an ERRα/ERRγ (Estrogen-Related Receptor) agonist — an 'exercise mimetic' peptide that mimics the metabolic effects of aerobic exercise. It increases oxidative metabolism, mitochondrial biogenesis, and endurance. 5 mg vial.
Reviewed by the AllPeptides.eu Editorial Team·Last reviewed: 2026-06-16
Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.
⚠️ For informational/educational purposes only. Not medical advice. We do not sell any products. Self-treatment carries serious risks — consult a healthcare professional. Disclaimer
Research monograph
See the full SLU-PP-332 encyclopedia page with mechanism, evidence tier, related variants and research context.
How It Works
SLU-PP-332 activates the ERRα and ERRγ receptors, leading to increased expression of oxidative metabolism genes. It promotes mitochondrial biogenesis, increases fatty acid oxidation, and improves muscle endurance — mimicking the benefits of aerobic exercise.
Quick Start
- Reconstitution: Add 1.0 mL of bacteriostatic water → 5 mg/mL.
- Typical dose: 250–500 mcg daily.
- Easy measurement: At 5 mg/mL, 5 units = 250 mcg.
- Storage: −20 °C / 2–8 °C after reconstitution.
Dosing Table — SLU-PP-332 5mg
Route: Subcutaneous | Frequency: Once daily
| Week | Dose | Units (per injection) |
|---|---|---|
| Weeks 1–2 | 250 mcg | 5 Units (0.05 mL) |
| Weeks 3–8 | 500 mcg | 10 Units (0.10 mL) |
Studies report administration once daily subcutaneously. Cycle for 4–8 weeks.
Related compounds
Reconstitution Steps
- Withdraw 1.0 mL of bacteriostatic water.
- Inject slowly.
- Swirl gently.
- Refrigerate at 2–8 °C.
Protocol Overview
- Goal: Mitochondrial biogenesis, oxidative metabolism, endurance enhancement.
- Schedule: Daily for 4–8 weeks.
Dosing Protocol
- Start: 250 mcg/day × 2 weeks.
- Increase: 500 mcg/day × 6 weeks.
- Cycle: 4–8 weeks on, 4 weeks off.
- Break between cycles: After a cycle (4–8 weeks), a washout period of 4–6 weeks is recommended. Research-stage — the washout may prevent metabolic adaptation to ERR activation.
Washout & Cycle Restart
When can I restart?
After a cycle (4–8 weeks), a washout period of 4–6 weeks is recommended. Research-stage — the washout may prevent metabolic adaptation to ERR activation.
Minimum wait period: 4 weeks
Storage Instructions
- Lyophilized: −20 °C.
- Reconstituted: 2–8 °C · use within 3 weeks.
Important Notes
- Research peptide — limited human data.
- Use sterile technique.
Potential Benefits & Side Effects
Potential Benefits:
- Increased mitochondrial biogenesis.
- Improved aerobic endurance.
- Enhanced oxidative metabolism.
- Potential body composition support.
Potential Side Effects:
- Limited safety data.
- Mild injection site reaction.
⚠️ Serious Warnings & Long-Term Risks
The following warnings are based on published literature, FDA labels, and post-marketing surveillance. They do not constitute medical advice. Consult a healthcare professional.
ERRα agonist — unclear long-term safety
As an ERRα agonist, mimics exercise metabolically. No human studies. Theoretical risk of metabolic dysregulation with chronic use.
📄 bioRxiv 2023 — Bhatt et al.References
- Nature Medicine — ERR agonists mimic the benefits of exercise
View Source - Cell Reports — SLU-PP-332 and muscle endurance
View Source
External Sources & Regulatory Status
Regulatory Approvals
Research-only — ERRα/γ agonist (exercise mimetic)
Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.
Continue Your Research
Explore tools and guides related to this protocol.
Important Disclaimer
The content of this website is provided exclusively for informational and educational purposes within the context of research literature.
Read the full Disclaimer →